Skip to content

Public FDA record

Z-0592-2012: Orbit and Orbit Micro Subcutaneous infusion set Triad alcohol wipes are co-packaged with the Orbit devic

Recall record Z-0592-2012 for ICU Medical, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0592-2012
Company in FDA record
ICU Medical, Inc.
FDA classification date
Jan 11, 2012
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 17, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

The recall was initiated because ICU Medical Inc. has become aware of the market recall of the Triad Group's alcohol prep pads, alcohol swabs, and alcohol swabsticks manufactured by Triad in the United States and marketed under various brand names. The Triad alcohol prep pads have the potential contamination of the bacteria, Bacillus cereus. The Triad Group alcohol prep pads have been copackaged

Source facts

Action
The firm, ICU Medical, Inc., sent an "IMPORTANT-Important Information About Triad Group's Alcohol Prep Pads" letter dated March 2, 2011 (via email) to their distributors. Hard copy notices were shipped (via next day express delivery with receipt confirmation) to all their customers. The Important letter provides the customers with an explanation of the problem identified and an action to be taken. Customers were informed that the Orbit and Orbit Micro subcutaneous infusion sets as well as the IV start kits are not contaminated and may continue to be used according to the directions for use. The issue is confined to the actual Triad alcohol prep pad products. Patients and healthcare providers should not use the alcohol prep pads packaged with these devices and should instead use an alternate alcohol prep pad that is not involved with the Triad Group recall. ICU Medical has halted all shipments of product that contain the Triad alcohol prep products to its distribution network. An alternate wipe has been qualified and is now being shipped in new orders. Customers were instructed to forward the Important letter to their customers and on to any end users of the devices. For Orbit and Orbit Micro devices, patients are instructed to immediately discontinue using the Triad alcohol prep pads included in the Orbit packaging and dispose of those pads in the trash. Patients should use an alternative prep pad that is not subject to the Triad recall. For IV Start Kits, distributors and users are instructed to place the enclosed label on the device prior to use. Additional labels can be obtained by contacting ICU Customer Service Monday through Friday between the hours of 8:30AM and 4:00PM Pacific Standard time: (800) 866-9025 and select option 8, or email the following address: customerservice@icumed.com. Customers may also contact regulatory@icumed.com for MSWord template file for Avery 5160 labels and print additional labels. Customers were instructed to complete
Initiated
2011-03-01
Root cause
Pending
Terminated
2013-02-22
Distribution
Worldwide distribution: USA (Nationwide) and countries of: Austria, Belgium, Chile, Cyprus, CZ, France, Germany, Great Britain, Greece, Israel, Italy, Lithuania, Netherland, Poland, Russia, Saudi Arabia, Sweden, and Switzerland.
Recall number
Z-0592-2012
Recall status
Terminated
CDRH record ID
105694
FDA classified
2012-01-11
Recall event number
60524

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗